A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species

Dysregulation of osteoclast-osteoblast balance, resulting in abnormal bone remodeling, is responsible for postmenopausal osteoporosis (PMOP) or other secondary forms of osteoporosis. We demonstrated that dictamnine (DIC), a novel RANKL-targeted furoquinoline alkaloid, inhibits osteoclastogenesis by...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Puiian, Lv, Zheng, Li, Jinglan, Wei, Qiushi, Xu, LiangLiang, Fang, Bin, Luo, Yiwen, He, Mincong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652067/
https://www.ncbi.nlm.nih.gov/pubmed/36388169
http://dx.doi.org/10.1155/2022/5982014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652067/
https://www.ncbi.nlm.nih.gov/pubmed/36388169
http://dx.doi.org/10.1155/2022/5982014

Ejemplares similares